JPRN-UMIN000004517招募中未知
Safety and efficacy of strontium-89 for prostate cancer with painful bone metastases in Japanese patients - Feasibility of strontium-89 for prostate cancer with painful bone metastases in Japanese patients
Yokohama City Medical Center0 个研究点目标入组 100 人开始时间: 2010年11月8日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •(1) Severe myelosuppression *Severe myelosuppression should be measured by hematologic functions (platelets < 50,000/mm3, WBC < 2,000/mm3, neutrophils < 1,000/mm3, Hb < 8.0/dL). (2) Diagnosis of disseminated intravascular coagulation syndrome (DIC) (3) Severe renal dysfunction (e.g. renal failure of NCI Common Toxicity Criteria Grade 3/4)
研究者
相似试验
已完成
2 期
Effect of Strontium-89 on painful bone metastases in zoledronic acid received patients with prostate cancerProstate CancerJPRN-UMIN000004718Keio University Shool of Medicine Department of Urology10
招募中
不适用
A Clinical Trial for Efficacy and Safety of PSE on prostate gland healthKCT0004316Chung-Ang Univerisity Hospital100
尚未招募
不适用
Evaluation of safety and efficacy in prostate cancer patients treated with focal low-dose-rate brachytherapyProstate cancerJPRN-UMIN000030509Kitasato University School of Medicine, Department of Urology20
尚未招募
不适用
Clinical efficacy and safety of prostatic periapical triangle block for transperineal cognitive fusion prostate biopsy and rectal hydrogel spacer injection.prostate cancerJPRN-UMIN000041610Department of Urology, Saitama Medical Center, Saitama Medical University190
进行中（未招募）
不适用
The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 3 years in the treatment of knee osteoarthritis. A prospective multicentre, international, double-blind, placebo-controlled study.MedDRA version: 7.0Level: PTClassification code 10031161OsteoarthritisEUCTR2005-002494-75-ATInstitut de Recherches Internationales Servier1,680